Measurement of plasma ammonia is affected in patients receiving asparaginase therapy.
D000641:Ammonia / Q000097:blood*; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001215:Asparaginase / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D013997:Time Factors
D000970:Antineoplastic Agents; D000641:Ammonia; D001215:Asparaginase